Abstract: Der vorzeitige Samenerguß gilt als eine der am stärksten verbreiteten sexuellen Fehlfunktionen des Mannes und bleibt dennoch weitestgehend unterdiagnostiziert und ungenügend behandelt. Während die tatsächliche Verbreitung der vorzeitigen Ejakulation schwer nachzuweisen ist, belegen epidemiologische Studien, daß die Zahl der Männer, die daran leiden, sich irgendwo zwischen 1 % und 75 % bewegt [1]. Tatsächlich ist die Erörterung der Verbreitung nur einer der Faktoren, die die Definition sowohl der Krankheit wie auch des Ausmaßes des Problems, das bis heute Zündstoff für Diskussionen und Auseinandersetzungen liefert, verschleiern. Das historische Fehlen einer Akzeptanz und Anerkennung einer neurobiologischen Komponente hat dazu geführt, daß der vorzeitige Samenerguß unter medizinischen Fachleuten kaum als echte Krankheit anerkannt wird. Obwohl die neurobiologische Ursache vom vorzeitigen Samenerguß zunehmend Bestätigung findet, bleiben viele Zweifel bestehen. Dieser Artikel befaßt sich schwerpunktmäßig mit der Anatomie und Physiologie der Ejakulation.
Introduction
Premature ejaculation (PE) is arguably the most prevalent male sexual dysfunction, yet it remains shrouded in clinical ambiguity. Prevalence estimates in existing literature vary dramatically, ranging from 1% to 75%, largely due to the lack of a universally accepted definition. Historically, PE was often dismissed as a purely psychological "malfunction" or a lack of self-control. However, modern research published in Blickpunkt der Mann argues for a paradigm shift, recognizing PE as a complex neurobiological disorder rooted in specific physiological and neurochemical pathways.
Anatomical and Physiological Foundations
Ejaculation is not a singular event but a coordinated two-stage reflex involving distinct neurological levels and anatomical structures.
- Emission: This phase involves the secretion of fluids from the prostate, seminal vesicles, and ampullae of the ductus deferens into the posterior urethra. This is primarily a sympathetic reflex controlled at the Th12–L3 spinal level.
- Expulsion: This is the rhythmic ejection of semen from the urethra, driven by the contraction of the bulbocavernosus and ischiocavernosus muscles. This phase is controlled at the S2–S4 sacral level.
Understanding these anatomical structures is crucial for distinguishing between the autonomic processes of emission and the somatic processes of expulsion. The corpus spongiosum, highlighted in anatomical diagrams, plays a central role as the conduit for the final expulsion phase.
The Neurobiology of Control: The Serotonin Brake
The "mystery" of PE often lies in the threshold of the ejaculatory reflex. While the spinal reflex is the physiological "default," the brain exerts "top-down" inhibitory control to modulate timing. Serotonin (5-HT) serves as the primary neurotransmitter in this inhibitory circuit, acting as a biological "brake."
The effect of serotonin is highly receptor-specific, which complicates pharmacological intervention:
- 5-HT1A receptors: Activation of these receptors tends to shorten ejaculatory latency, effectively speeding up the process.
- 5-HT1B and 5-HT2C receptors: These are associated with prolonging latency, acting as the primary inhibitory signals.
PE can be conceptualized as either a failure of this cerebral inhibition or an abnormally low threshold within the spinal reflex arc. This neurochemical complexity explains why non-selective treatments, such as standard SSRIs, can have varying effects on sexual function.
Clinical Framework and Diagnosis
To move past the "confusions and contradictions" of the past, the authors advocate for a diagnostic framework based on three objective and subjective pillars:
- Intravaginal Ejaculatory Latency Time (IELT): A measurable metric used in clinical settings, with common cutoffs ranging from 15 to 60 seconds.
- Loss of Voluntary Control: The patient's subjective sense of being unable to delay ejaculation once a certain level of arousal is reached.
- Personal and Interpersonal Distress: The psychological impact on the patient and their partner, which is often the primary driver for seeking treatment.
Conclusion and Future Directions
The recognition of PE as a neurobiological condition is a vital step toward improving patient care and reducing the stigma associated with the disorder. Currently, barriers such as a "lack of time and knowledge" among clinicians prevent many men from initiating conversations about their sexual health. Future research must focus on developing more selective pharmacological targets—specifically 5-HT receptor agonists and antagonists—and enhancing medical education to ensure that this common dysfunction is addressed with scientific rigor.
Summary updated